GOSS
Gossamer Bio, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.18
−0.17%Margins
Gross margin
99.6%
EBITDA margin
-384.7%
EBIT margin
-311.7%
Net margin
-235.0%
FCF margin
-305.2%
133.2%
Return on equity
-162.9%
Return on assets
302.4%
Return on invested capital
0.52x
Asset turnover
-$162.6M
Cash from operations
$0.12
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026